Jonathan has a broad practice, spanning international regulatory and internal investigations, cross border litigation and arbitration. His sector focus includes financial institutions, pharmaceuticals, private equity and consumer products, and he has advised on a wide-range of issues in these areas.

Jonathan’s practice also has a significant cross border element. In recent years, he has advised international clients on matters involving Hong Kong, the PRC, the US, Europe, North East Asia, South East Asia and South America.